Evidence map›Paper›PMID 35371059›Full record

ArticleFrontiers in immunology2022

Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma.

Zifei Wang, Yu Zhong, Zefan Zhang, Kaiqian Zhou, Zhihao Huang, Hao Yu, Longqi Liu, Shiping Liu, Huanming Yang, Jian Zhou and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zifei WangCollege of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
Yu ZhongBeijing Genomics Institute at Shenzhen, Shenzhen, China.
Zefan ZhangZhong-Hua Precision Medical Center, Zhongshan Hospital, Fudan University-BGI, Shanghai, China.
Kaiqian ZhouZhong-Hua Precision Medical Center, Zhongshan Hospital, Fudan University-BGI, Shanghai, China.
Zhihao HuangBeijing Genomics Institute at Shenzhen, Shenzhen, China.
Hao YuBeijing Genomics Institute at Shenzhen, Shenzhen, China.
Longqi LiuBeijing Genomics Institute at Shenzhen, Shenzhen, China.
Shiping LiuBeijing Genomics Institute at Shenzhen, Shenzhen, China.
Huanming YangCollege of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
Jian ZhouDepartment of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Jia FanDepartment of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
Liang WuCollege of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
Yunfan SunZhong-Hua Precision Medical Center, Zhongshan Hospital, Fudan University-BGI, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have demonstrated that the T-cell receptor (TCR) repertoire is associated with prognosis and immune therapy response in several types of cancer. However, the comprehensive features of TCR repertoire in tumor-infiltrating and circulating T cells, as well as its clinical significance of diagnosis in hepatocellular carcinoma (HCC) patients, are still unknown. In this study, we perform paired tumor/peritumoral tissues and peripheral blood samples from 58 patients with HCC and sequenced them with high-throughput TCR to comprehensively analyze the characteristics of TCR and the clinical significance of peripheral TCR sequence. By exploring the abundance and diversity of TCR repertoires, we observe that there was a significantly higher TCR diversity in peripheral blood than in tumoral and peritumoral tissues, while tumoral and peritumoral tissues showed similar TCR diversity. A substantial difference in the usage frequencies of several Vβ, Jβ genes, and TCRβ VJ pairings was found among three types of tissues. Moreover, we reveal that HCC patients have a unique profile of TCR repertoire in peripheral blood in contrast to healthy individuals. We further establish an HCC diagnostic model based on TCRβ VJ pairing usage in peripheral blood, which yields a best-fit area under the curve (AUC) of 0.9746 ± 0.0481 (sensitivity = 0.9675 ± 0.0603, specificity = 0.9998 ± 0.0007, average of 100 repeats) in the test set. Our study describes the characteristics of tissue infiltration and circulating T-cell bank in patients with HCC and shows the potential of using circulating TCR sequence as a biomarker for the non-invasive diagnosis of patients with HCC.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsHumansPrognosisReceptors, Antigen, T-CellT-LymphocytesReceptors, Antigen, T-Cellbiomarkercomplementarity-determining region 3diagnosishepatocellular carcinomaT-cell repertoire

Identifiers

PMID35371059
PMCPMC8965762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.